NYT turns gaze on measles outbreak; GSK faces chickenpox vax shortage;

> The New York Times editorial board has turned its gaze to the British measles outbreak. Item

> A court has allowed a woman who had a vaccine damages case dismissed to seek lawyer's fees. News

> Intercell ($ICLL) has won FDA approval for a pediatric indication of its Japanese encephalitis vaccine. Release (pdf)

> A Singapore-made H1N1 vaccine has entered Phase I clinical trials. Article

> Surging demand for GlaxoSmithKline's ($GSK) chickenpox vaccine in New Zealand has created a shortage. News

On-Demand Webinar

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research. Sign up today for this informative webinar to learn how you can leverage one of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.